Evidence mapPaperPMID 42373877Full record

ArticleJournal of cardiovascular translational research2026

The Immediate Impact of Infarct Size on the Systemic Inflammatory Response: IL-6 as Central Mediator Identified through Biomarker and Proteomic Profiling.

Jonathan Los, Frans B Mensink, Özlem Bulut, Ilse H Hol, Aysun Cetinyurek-Yavuz, Niels P Riksen, Saloua El Messaoudi, Jan H Cornel, Robert-Jan M van Geuns

Abstract read
In one paragraph

Article in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jonathan LosDepartment of Cardiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-6731-0965
Frans B MensinkDepartment of Cardiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Özlem BulutDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Ilse H HolDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Aysun Cetinyurek-YavuzDepartment of IQ Health, Radboud University Medical Center, Nijmegen, the Netherlands.
Niels P RiksenDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Saloua El MessaoudiDepartment of Cardiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Jan H CornelDepartment of Cardiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Robert-Jan M van GeunsDepartment of Cardiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands. robertjan.vangeuns@radboudumc.nl.ORCID http://orcid.org/0000-0003-2943-5932

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial infarction (MI) induces an inflammatory response that may be amenable to targeted therapy. This cohort study evaluated the systemic inflammatory burden across different infarct sizes using serial measurements of C-reactive protein (CRP), interleukin-6 (IL-6), and targeted inflammatory proteomics (Olink's Target 96 Inflammation panel) during hospitalization and up to 12 weeks post-MI. Baseline IL-6 concentrations were progressively higher with increasing infarct size, with differential temporal trajectories observed across infarct size strata (P for interaction < 0.001), a finding confirmed by proteomic analysis (P

Indexed as

InflammationInflammation MediatorsInterleukin-6Myocardial InfarctionMyocardiumProteomicsAngiogenic ProteinsBiomarkersC-Reactive ProteinFemaleHepatocyte Growth FactorHumansMaleTime FactorsUrokinase-Type Plasminogen ActivatorAngiogenic ProteinsBiomarkersC-Reactive ProteinHepatocyte Growth FactorHGF protein, humanIL6 protein, humanInflammation MediatorsInterleukin-6Urokinase-Type Plasminogen ActivatorC-reactive proteinCytokinesInflammationInterleukin-6Myocardial infarction

Identifiers

PMID42373877
PMCPMC13314833

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.